900181851 | ommc | 05179465 | | 8721738 | 6/21/2006 12:00:00 am | acute on chronic renal failure | | dis | admission date: 4/12/2006 report status:discharge date: 7/22/2006 final discharge orders hackbarth , clair e 522-03-89-2call ba sa la noservice: cardischarge patient on: 1/8/06 at 04:00 pmcontingent upon attending evaluationwill d/c order be used as the d/c summary: yesattending: vannuland , lyle kevin , m.d.code status:no cpr , no defib , no intubationdisposition: home w/ servicesdischarge medications:acetylsalicylic acid 325 mg po dailyoverride notice: override added on 9/16/06 by papich , lucien l , m.d. on order for coumadin po ( ref # 895231165 )potentially serious interaction: aspirin & warfarinreason for override: md awareallopurinol 100 mg po dailyoverride notice: override added on 9/16/06 by messana , hoyt j , m.d. on order for coumadin po ( ref # 895231165 )serious interaction: allopurinol & warfarinreason for override: md awarecolace ( docusate sodium ) 100 mg po bidnexium ( esomeprazole ) 20 mg po dailyferrous sulfate 325 mg po bidfood/drug interaction instruction avoid milk and antacidglipizide 5 mg po bidisosorbide dinitrate 5 mg po tidlevoxyl ( levothyroxine sodium ) 100 mcg po dailyoverride notice: override added on 9/16/06 by kabrick , fletcher e , m.d. on order for coumadin po ( ref # 895231165 )serious interaction: levothyroxine sodium & warfarinreason for override: md awareativan ( lorazepam ) 0.5 mg po bid prn anxietytoprol xl ( metoprolol succinate extended release )100 mg po daily food/drug interaction instructiontake consistently with meals or on empty stomach.pravastatin 40 mg po bedtimefood/drug interaction instructionavoid grapefruit unless md instructs otherwise.override notice: override added on 9/16/06 by beedham , faustino n , m.d. on order for coumadin po ( ref # 895231165 )potentially serious interaction: pravastatin sodium &warfarin reason for override: md awareprevious override information:override added on 9/16/06 by buffone , boris m , m.d.potentially serious interaction: niacin , vit. b-3 &pravastatin sodium reason for override: nd awaremultivitamin therapeutic ( therapeutic multivi... )1 tab po dailyoverride notice: override added on 9/16/06 by dalziel , cruz j , m.d. on order for pravastatin po ( ref # 011084372 )potentially serious interaction: niacin , vit. b-3 &pravastatin sodium reason for override: nd awaretorsemide 40 mg po bid starting today ( 9/21 )coumadin ( warfarin sodium ) 1 mg po qpmstarting routine , 20:00 ( standard admin time )food/drug interaction instructionno high vitamin-k containing foodsalert overridden: override added on 9/16/06 bypostlethwaite , rosendo a , m.d.serious interaction: levothyroxine sodium & warfarinserious interaction: allopurinol & warfarinpotentially serious interaction: aspirin & warfarinpotentially serious interaction: pravastatin sodium &warfarin reason for override: md awarediet: patient should measure weight dailydiet: fluid restrictiondiet: house / low chol/low sat. fatdiet: house / ada 2100 cals/dydiet: 2 gram sodiumactivity: walking as toleratedfollow up appointment( s ):dr. gregorio pensis pcp ( 570 ) 374-9489 june at 12:15pm scheduled ,dr. lucien machowski 051-469-9935 fbmh cardiology june at 11am scheduled ,dr. raymon rentar 072-561-0481 suohc thoracic surgery november at 4pm scheduled ,dr. lyndon palos ( 115 ) 879-7452 puoh thoracic oncology november at 3pm scheduled ,arrange inr to be drawn on 4/29 with f/u inr's to be drawn every3 days. inr's will be followed by pcp erick rottinghousallergy: nkaadmit diagnosis:hyperkalemia , acute on chronic renal failureprincipal discharge diagnosis ;responsible after study for causing admission )acute on chronic renal failureother diagnosis;conditions , infections , complications , affecting treatment/staychf ( congestive heart failure ) cad ( coronary artery disease ) htn( hypertension ) dm ( diabetes mellitus ) gerd ( gastroesophageal refluxdisease ) hypothyroidism ( hypothyroidism ) mitral regurgitation( 2 ) lung ca s/p rul lobectomy and rll wedge resection ( lung cancer )endometrial ca s/p tah/bso( endometrial cancer ) basal cell ca ( basal cellcarcinoma ) cri ( chronic renal dysfunction ) renal artery stenosis s/pl stent ( renal artery stenosis ) recurrent flash pulm edema ( pulmonaryedema )operations and procedures:noneother treatments/procedures ( not in o.r. )nonebrief resume of hospital course:cc: hyperkalemia in setting of worsening renal insufficiencyhpi: pt is a 75 f with multiple medical problems including cad s/p pcito om1 '91 , lad '97 , lcx '01 , rca '02 , dyslipidemia , chf with an ef 30-35%in 9/21 ( dry weight 158lbs ) , mv repair 8/27 , htn , afib oncoumadin , pericardial effusion s/p window 6/10 ,ras s/p left renal artery stent , and cri with a baseline cr 1.9-2.2. atbaseline , she lives at home. she is alert and oriented.she receives assistance from vna. 1 day prior to admission , pt was seenin cardiology clinic by dr. steven nonemaker her cr was noted tobe 2.3 and her potassium 5.3. the following day , pt. was instructed tohave her basic metabolic panel rechecked. her cr was noted to be 2.6 andher potassium 5.5. she was advised to present to the fmc ed for furtherevaluation and management of hyperkalemia in the settingof worsening renal insufficiency.pmhx:cad s/p pci to om1 '91 , lad '97 , lcx '01 , rca '02 , om1 '91dyslipidemiachf ef 30-35% 9/21htnmv repair 8/27afib on coumadinnsvtpericardial effusion s/p pericardial window 6/10ras s/p l renal artery stentcri baseline cr 1.9-2.2gerdpvd s/p r 5th toe amputationiron deficiency anemiabronchoalveolar lung cancer s/p rul lobectomy and rll wedge resection ,uterine ca s/p tah/bsobcc l upper liphypothyroidismniddmhome meds:torsemide 60 po bid , synthroid 100 , glipizide 5bid , iron 325 bid , allopurinol 100mg daily , asa 325 , ativan 0.5 bid prn ,coumadin 1mg po qhs , toprol xl 100mg daily , metolazone 2.5mg prn , nexium20mg daily , k 20 meq bid , pravastatin 40mg , colace 100 mg po bidall: nkdasoc hx: married. lives in holldi bockpu sairv quit smoking 10 yrs ago. ( + )60 pk-yr.no etoh or drugs.admission exam:t 97.5 hr irreg 76 bp 124/56 o2sat 97% ragen: nadheent: l surgical pupil. eomi. mmm. op clear.cv: jvp 6cm , irreg , no m/r/gpulm: crackles rllabd: soft , umbilical hernia , ntnd. +bsext: trace edema lle , distal pulses not palpable. extremities warm. softnodule over left shin likely lipoma , no clubbing/cyanosis.admission labs: cr 2.7 , k 4.4 , hct 37.3 , bnp 896 ( 644-781 ) , inr 1.5studies:ekg - afib 90 , lbbb morphology , l axis deviation , loss of anterior forcesinferior + precordial leads , qtc 515cxr - lobectomy staples in rul , ill defined r basilar opacity ,mild pulm edema vs. pnarenal u/s - nlecho - ef 30% , lvh , inf/post/apical ak + hk of remaining walls ,rv function low nl , mild lae , trace to mild mr , mild trhospital course by systems and problems:renal: worsening renal insufficiency pt was admitted with worseningrenal insufficiency. a ua was dirty and urine culture was sent.pt was not treated with antibiotics , as she was afebrile , asymptomatic ,and without leukocytosis. her febun was 35.9 , not consistent withintravascular depletion. on exam , she appeared euvolemic.a repeat echo revealed relatively unchanged systolic function.a renal ultrasound was within normal limits. it is unclear whatcaused the patient's vacillation in renal function. she likely hasa narrow range with respect to ideal volume status. she was continued on herhome torsemide dose while in house. her weight on discharge was 72.5 kg ( 159lbs ) , very close to her admission weight of 72.7 kg and to her designated dryweight of 159 lbs. her creatinine improved on its own from 2.7 on admissionto 1.9 on the day of discharge. 1.9 represents a value within herbaselne creatinine range of 1.8 to 2.2. she will need close follow up ofher renal functionhyperkalemia pt presented with hyperkalemia in setting of worsening renalinsufficiency. her peak creatinine was 5.5. she recevied kayex on the day ofadmission. subsequent creatinine measurements were in the 4's withoutk-binding treatment on the one hand or k supplementation on the other.pt. had been on k supplementation at home. her oral supplements are beingheld on discharge. she will need close follow up of her potassium andmay need to resume supplementation on an outpatient basis.cv:cad s/p multiple pci pt was continued on asa , bb , statin. she wasalso started on low dose isordil. her bp will need close monitoring on thisnew medication.bp pt was continued on bb and started on isordil , as above.on the day of discharge , her standing sbp dropped to 92 from 118 sitting.her hr remained in the 70s. she was asymptomatic. in light of these changes ,she was discharged on torsemide 40 mg po bid , lower than her home dose andin-hospital dose of 60 mg po bid. she was instructed not to walk withoutsupervision and to stand up slowly from seated position.chf pt was thought to be clinically euvolemic on exam. her bnp was in the800s. her repeat echo showed an ef of 30% , relatively unchanged fromprevious echo 3/24 she was continued on her home torsemide dose while inhouse and discharged on a lower dose of torsemide as described above.mvr stable.afib pt was rate controlled with bb. her inr was subtherapeutic onadmission. in light of this , her coumadin dose was increased from 1 to 2while in house. her inr rose to 1.9 on discharge. her coumadin dose wasdowngraded to 1. she will need close follow up of her inr.heme:iron deficiency anemia pt. was continued on iron. colonoscopy couldbe considered but may not be indicated given pt.'s prognosis from knownlung malignancy.onc:lung ca pt has cxr findings likely related to her knownmalignancy. she will f/u with her outpatient oncologist.pulm:o2 requirement pt was noted to desat to 87% while ambulating.home o2 was arranged. etiology of pt.'s new oxygen requirement likelyrelates to underlying lung malignancy , and perhaps to her chf - althoughshe appears compensated from that standpoint.endo: dm pt was treated with ssi while in house and was discharged onher home glipizide. she was continued on her home levoxyl.rheum: gout pt was continued on her prophylactic allopurinol.proph: nexium/coumadindischarge status: on discharge , pt. is afebrile , p 70s sbp 90s-110ssatting 95% 2l. exam unchanged from admission. hct 31 , cr 1.9 , inr 1.9disposition: pt is being discharged to home with vna servicesadditional comments: to pt:-you were admitted with worsening kidney function. an ultrasound of yourkidneys was normal and your kidney function improved.-during this hospitalization , we added a new medication called isordil 5mg three times per day. we decreased your dose of torsemide to 40 mgtwo times per day. in addition , we stopped your medicationcalled potassium. you will have your potassium levels checked and youroutpatient physicians will decide on whether you need to restart potassiumand at what level.-we arranged for you to have home oxygen. use it while sleeping andwhen you feel short of breath. do not smoke or cook on the stove whileusing oxygen. stay away from open flames.-do not stand up quickly from a seated position and do notwalk without supervision. we noticed your blood pressure is lowerwhen you stand and we do not want you to get dizzy and fall , especially asyou are on coumadin. do not drive.-return to the emergency room or call your doctor if you have increasingshortness of breath , weight gain , chest pressure or jaw pain , dizziness ,lightheadedness , palpitations , abdominal pain , vomiting , or diarrhea.-take prescription for blood draw to hho on 11/25 have inr , chem 7 , andmagnesium checked. as per script , results should be faxed both to dr. sterling guandique fax 404-329-6993 and to dr. jospeh olaya tel 051-469-9935to vna:-monitor o2 sat on home o2- do heart rate and blood pressure check- check weight - notify dr. robert avenoso 051-469-9935 if weightincreases or decreases by 2 pounds in 3 daysdischarge condition: fairto do/plan:pcp/cards:-monitor creatinine. pt.'s creatinine improved from 2.7 to 1.9. baseline1.8-2.2 in past. febun was 35.9% and bun/cr ratio was 20. we continuedtorsemide 60mg po bid. renal ultrasound was normal bilaterally.-monitor potassium. pt.'s k decreased from 5.5 to 4.1. she did notrequire potassium supplementation while in the hospital. her outpatientdose of potassium was held. this may need to be restarted if her potassiumdecreases below 4.-f/u official results of urine culture , send secondary to dirty ua.pt not treated as afebrile , asymptomatic , nl wbc count.-monitor hct - stable in low 30s. pt has known iron deficiency anemiaand is on iron.-monitor inr on coumadin. goal inr is 2-3. pt had been on 1 mg po qdcoumadin at home. her inr on admission was 1.5. she was treated withcoumadin 2 mg po qd. her inr rose to 1.9 on the day of discharge. she wasdischarged again on coumadin 1 mg po qd. vna should draw her inr on 4/29and fax results to her pcp.-monitor blood pressure on isordil. on low dose 5mg po tid currently.-monitor sob on home o2. pt. desatted to 87% while ambulating on ra. hersubjective shortness of breath improves tremendously on 2l. pet scansuggests progressive lung ca.-patient is dnr/dni and her healthcare proxy is her husband.no dictated summaryentered by: bueter , patrick d. , m.d. ( zt35 ) 1/8/06 @ 12 end of discharge orders